We are live on ! Find out more
KALV

KalVista Pharmaceuticals
KALV

Delisted

KALV was delisted on the 10th of June, 2026.

Back to rankings

73 hedge funds and large institutions have $244M invested in KalVista Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 28 increasing their positions, 14 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 14

67% more funds holding in top 10

Funds holding in top 10: 3 → 5 (+2)

60% more capital invested

Capital invested by funds: $153M → $244M (+$91.4M)

12% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 17

2.98% more ownership

Funds ownership: 73.98% → 76.96% (+3%)

4% less funds holding

Funds holding: 76 → 73 (-3)

Holders
73
Holders Change
-3
Holders Change %
-3.95%
% of All Funds
1.44%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.1%
New
19
Increased
28
Reduced
14
Closed
17
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$9.68M
2
Franklin Resources
Franklin Resources
California
+$3.7M
3
Victory Capital Management
Victory Capital Management
Texas
+$3.57M
4
Wellington Management Group
Wellington Management Group
Massachusetts
+$2.49M
5
SFM
Sphera Funds Management
Israel
+$1.93M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$10.3M
2
PC
Polar Capital
United Kingdom
-$9.72M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$2.61M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
-$1.01M
5
Neuberger Berman Group
Neuberger Berman Group
New York
-$682K
Name Holding Trade Value Shares
Change 		Change in
Stake
GCP
51
GSA Capital Partners
United Kingdom
$300K +$85K +6,515 +63%
Janus Henderson Group
52
Janus Henderson Group
United Kingdom
$283K +$208K +15,915 New
AG
53
Algert Global
California
$249K -$193K -14,767 -51%
California Public Employees Retirement System
54
California Public Employees Retirement System
California
$232K +$170K +13,050 New
QSS
55
Quantitative Systematic Strategies
Florida
$227K +$166K +12,738 New
New York State Common Retirement Fund
56
New York State Common Retirement Fund
New York
$214K – – –
RhumbLine Advisers
57
RhumbLine Advisers
Massachusetts
$194K +$3.11K +238 +2%
AllianceBernstein
58
AllianceBernstein
Tennessee
$180K – – –
Ensign Peak Advisors
59
Ensign Peak Advisors
Utah
$151K +$111K +8,506 New
AIG
60
American International Group
New York
$141K +$6.94K +532 +7%
NFG
61
Next Financial Group
Texas
$83K +$61.1K +4,683 New
Deutsche Bank
62
Deutsche Bank
Germany
$81K -$54.3K -4,159 -47%
Bank of America
63
Bank of America
North Carolina
$78K -$43.3K -3,315 -43%
Citigroup
64
Citigroup
New York
$45K +$25.5K +1,951 +337%
Legal & General Group
65
Legal & General Group
United Kingdom
$40K +$6.24K +478 +25%
BNP Paribas Financial Markets
66
BNP Paribas Financial Markets
France
$32.1K +$4.27K +327 +22%
Bank of Montreal
67
Bank of Montreal
Ontario, Canada
$28K +$7.27K +557 +55%
Rockefeller Capital Management
68
Rockefeller Capital Management
New York
$27K +$19.6K +1,500 New
Royal Bank of Canada
69
Royal Bank of Canada
Ontario, Canada
$22K +$16.5K +1,263 New
AIP
70
Ameritas Investment Partners
Nebraska
$18K – – –
VFA
71
Valeo Financial Advisors
Indiana
$3K – – –
PCM
72
Prelude Capital Management
New York
$3K +$2.4K +184 New
MAM
73
Meeder Asset Management
Ohio
$2K +$1.79K +137 New
DM
74
Deerfield Management
New York
– -$10.3M -890,668 Closed
Point72 Asset Management
75
Point72 Asset Management
Connecticut
– -$1.01M -87,000 Closed
1 2
3
4

KALV Hedge Fund Activity: Q4 2019 in Review

73 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in KalVista Pharmaceuticals (KALV) for Q4 2019, worth a combined $244M — up 60% from $153M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new KALV positions and 17 closed out — a net gain of 2 holders — while 28 added to existing stakes and 14 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $9.68M. The largest seller was Deerfield Management, exiting entirely with an estimated $10.3M sold.

  • 73 institutional investors held KalVista Pharmaceuticals (KALV) as of Q4 2019, down from 76 in Q3 2019.
  • Funds reported $244M of KalVista Pharmaceuticals stock for Q4 2019, up 60% quarter-over-quarter.
  • 19 funds opened new KalVista Pharmaceuticals positions in Q4 2019 and 17 closed out, a net change of +2 holders.
  • The largest KalVista Pharmaceuticals buyer in Q4 2019 was Fidelity Investments, an estimated $9.68M added.
  • The largest KalVista Pharmaceuticals seller in Q4 2019 was Deerfield Management, an estimated $10.3M sold.

Based on aggregated 13F filings for Q4 2019.